Anti-Cancer Agents in Medicinal Chemistry

(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Editor-in-Chief

Simone Carradori
Department of Pharmacy
“G. d’Annunzio” University of Chieti-Pescara
Chieti
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 11 Issue: 1, January

Editorial [Hot Topic: Rising of Phosphatases as Targets of Cancer Treatment (Guest Editor: Petr Heneberg)]

Volume:11   Issue: 1
Pp: 1-3
Petr Heneberg
DOI: 10.2174/187152011794941226
Published on: 01 March, 2012

Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer Development

Volume:11   Issue: 1
Pp: 4-18
Hirota Fujiki and Masami Suganuma
DOI: 10.2174/187152011794941163
Published on: 01 March, 2012

Can We Effectively Degrade Microcystins? - Implications on Human Health

Volume:11   Issue: 1
Pp: 19-37
Armah A. de la Cruz, Maria G. Antoniou, Anastasia Hiskia, Miguel Pelaez, Weihua Song, Kevin E. O'Shea, Xuexiang He and Dionysios D. Dionysiou
DOI: 10.2174/187152011794941217
Published on: 01 March, 2012

Protein Phosphatase 2A as a Potential Target for Anticancer Therapy

Volume:11   Issue: 1
Pp: 38-46
Peter Kalev and Anna A. Sablina
DOI: 10.2174/187152011794941172
Published on: 01 March, 2012

In-Gel Protein Phosphatase Assays and Other Useful Methods for the Detection of Protein Phosphatase Activities

Volume:11   Issue: 1
Pp: 47-53
Atsuhiko Ishida and Isamu Kameshita
DOI: 10.2174/187152011794941280
Published on: 01 March, 2012

Recent Advances in Protein Tyrosine Phosphatase Detection Using Chemical Probes

Volume:11   Issue: 1
Pp: 54-63
Kyeong Lee, Hyo Jin Kang, Yan Xia and Sang J. Chung
DOI: 10.2174/187152011794941208
Published on: 01 March, 2012

Regulatory Cascades of Protein Phosphatases: Implications for Cancer Treatment

Volume:11   Issue: 1
Pp: 64-77
Noor Jailkhani, Virendra K. Chaudhri and Kanury V.S. Rao
DOI: 10.2174/187152011794941253
Published on: 01 March, 2012

PTPN13/PTPL1: An Important Regulator of Tumor Aggressiveness

Volume:11   Issue: 1
Pp: 78-88
Gilles Freiss and Dany Chalbos
DOI: 10.2174/187152011794941262
Published on: 01 March, 2012

SHP-1 in Cell-Cycle Regulation

Volume:11   Issue: 1
Pp: 89-98
Pilar Lopez-Ruiz, Javier Rodriguez-Ubreva, Ariel Ernesto Cariaga, Maria Alicia Cortes and Begona Colas
DOI: 10.2174/187152011794941154
Published on: 01 March, 2012

PRL-3, An Emerging Marker of Carcinogenesis, Is Strongly Associated with Poor Prognosis

Volume:11   Issue: 1
Pp: 99-108
Katarzyna Guzinska-Ustymowicz and Anna Pryczynicz
DOI: 10.2174/187152011794941145
Published on: 01 March, 2012

Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment

Volume:11   Issue: 1
Pp: 109-132
Caroline Nunes-Xavier, Carlos Roma-Mateo, Pablo Rios, Celine Tarrega, Rocio Cejudo-Marin, Lydia Tabernero and Rafael Pulido
DOI: 10.2174/187152011794941190
Published on: 01 March, 2012

Tumor-Derived Extracellular Fragments of Receptor Protein Tyrosine Phosphatases (RPTPs) as Cancer Molecular Diagnostic Tools

Volume:11   Issue: 1
Pp: 133-140
Sonya E.L. Craig and Susann M. Brady-Kalnay
DOI: 10.2174/187152011794941244
Published on: 01 March, 2012

High-Throughput Methods in Identification of Protein Tyrosine Phosphatase Inhibitors and Activators

Volume:11   Issue: 1
Pp: 141-150
Elina Mattila and Johanna Ivaska
DOI: 10.2174/187152011794941235
Published on: 01 March, 2012

Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors

Volume:11   Issue: 1
Pp: 151-163
Pramod C. Nair
DOI: 10.2174/187152011794941181
Published on: 01 March, 2012

Metal-Based Inhibitors of Protein Tyrosine Phosphatases

Volume:11   Issue: 1
Pp: 164-171
Liping Lu and Miaoli Zhu
DOI: 10.2174/187152011794941271
Published on: 01 March, 2012